PREVIOUS
✖
Nasal vaccine - BBV154
August 17 , 2021
1124 days
843
0
- India’s first nasal vaccine against COVID-19 has received the nod to conduct phase 2 and 3 clinical trials by the Department of Biotechnology.
- Nasal Covid Vaccine has been developed by Bharat Biotech.
- The nasal vaccine is the first of its kind COVID-19 vaccine that is undergoing human clinical trials in India.
Note
- Bharat Biotech has developed the first ever nasal vaccine called BBV154.
- It is a novel adenovirus vectored.
- This intranasal vaccine was developed to build immunity against COVID-19.
Leave a Reply
Your Comment is awaiting moderation.